President Trump has signed into law the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act or Act),1 sweeping legislation intended to bolster the nation’s response to the COVID-19 pandemic. In addition to offering economic relief to individuals and impacted businesses, the Act shores up the nation’s supply of drugs and equipment, expands coverage of COVID-19 testing and preventative services, addresses health care workforce needs, eases restrictions on telehealth services during the crisis, increases Medicare regulatory flexibility, and authorizes $100 billion for eligible health care providers, among many other things. This was the third emergency COVID-19 response measure signed into law to date, following the Coronavirus Preparedness and Response Supplemental Appropriations Act2 and the Families First Coronavirus Response Act (Families First Act).3 Congressional leaders have indicated that additional legislative action is contemplated.

Authors: Scot T. Hasselman Robert J. Hill Carol Colborn Loepere Kevin M. Madagan Paul W. Pitts James F. Segroves Nicole J. Aiken-Shaban Julia Krebs-Markrich John D. Kendzior Jamie Knauer Arielle R. Lusardi Sonia T. Nguyen Sung W. Park Ryan M. Pate

Disposable mask against Coronavirus 2019-nCoV droplet infection and an antibiotic syringe

Download our in-depth analysis of the major health care policy and funding provisions in the CARES Act. We would be pleased to provide you with additional information or answer any questions you may have about the Act, the status of Department of Health and Human Services implementation efforts, or any other aspect of the government policy response to the COVID-19 pandemic.

For more information on this issue, please contact any of the authors listed in the white paper. In addition, our broader Reed Smith Coronavirus team includes multidisciplinary lawyers from Asia, EME and the United States who stand ready to advise you on the issues discussed in the white paper or others you many face related to COVID-19, including those specific to the CARES Act.

Businesses may also be interested in Reed Smith’s CARES Act Overview, which covers all portions of the Act. Additional information on the legal and business implications of COVID-19 is available at the Reed Smith Coronavirus (COVID-19) Resource Center, at the firm's CARES Act Resource Center, or by contacting us at COVID-19@reedsmith.com.

Download the PDF below to learn more!


  1. P.L.116-136; available at congress.gov.
  2. P.L. 116-123, available at congress.gov.
  3. Pub. L. No. 116-127, available at congress.gov.